首页 > 最新文献

Actas espanolas de psiquiatria最新文献

英文 中文
Variables Associated with the Use of Psychotropic Medications by Brazilian University Students. 与巴西大学生使用精神药物相关的变量
IF 1 4区 医学 Q4 NEUROSCIENCES Pub Date : 2024-12-01 DOI: 10.62641/aep.v52i6.1753
Cássia Regina Primila Cardoso Berti, Alice Milani Nespollo, Moises Kogien, Evelyn Kelly Das Neves Abreu, Samira Reschetti Marcon, Tatiane Lebre Dias

Background: University life is a phase of developing personal and professional skills, but it brings challenges such as distancing from family and supporting networks, difficulties with academic tasks, loneliness, new relationships, competitiveness, and social, socioeconomic, and psychological vulnerability, among others. These conditions can lead to the development of illnesses such as anxiety, depression, sleeping disorders, suicide, self-harming, and excessive drug use, including psychotropic medications. Therefore, this study aimed to evaluate the use of psychotropic medications and its association with sociodemographic, academic, behavioral, and health variables in Brazilian university students.

Methods: A cross-sectional, quantitative research, with a sampling of 524 students from a Brazilian public Higher Education Institution (Federal University of Mato Grosso - UFMT). The collection took place from October 10th to December 30th, 2022. An online questionnaire was applied with sociodemographic and clinical questions-the General Anxiety Disorder Questionnaire-7 (GAD-7) and the Patient Health Questionnaire-9 (PHQ-9). The data were descriptively and inferentially analyzed; in the descriptive analysis, the absolute (FA) and relative (FR) frequencies of each category investigated were presented; and for bi- and multivariate analyses, Poisson regression with robust estimation was used.

Results: The participants were at the median age of 22 years old, the majority were female (69.7%), heterosexual (68.1%), with medium/high subjective social status (82.4%) and without being involved in a romantic relationship (54%). The prevalence of psychotropic medication use was 26.1%, considering that 17.5% was not prescribed by a medical professional. The most used class of medications was antidepressants (91 participants), followed by natural medicines (38 participants). Among the segments associated with the use of psychotropic drugs were female individuals, romantic relationships, perception of academic performance by postgraduate students, and previous diagnoses of mental or mood disorders (depression and anxiety).

Conclusions: The results obtained highlight the importance of research on mental health among university students, especially regarding the use of psychotropic drugs, which must be monitored by a qualified professional. At the university, these data can be important for the development of policies aimed at health and life quality, in addition to contributing to the strengthening of national and international partnerships, and promoting the scientific production in the area.

背景:大学生活是发展个人和专业技能的阶段,但它也带来了挑战,如与家庭和支持网络的距离,学业任务的困难,孤独感,新关系,竞争以及社会,社会经济和心理脆弱性等。这些情况可能导致诸如焦虑、抑郁、睡眠障碍、自杀、自残和过度使用药物(包括精神药物)等疾病的发展。因此,本研究旨在评估精神药物的使用及其与巴西大学生社会人口学、学术、行为和健康变量的关系。方法:横断面定量研究,抽样524名学生来自巴西公立高等教育机构(马托格罗索联邦大学- UFMT)。展览于2022年10月10日至12月30日举行。采用社会人口学和临床问题在线问卷-一般焦虑障碍问卷-7 (GAD-7)和患者健康问卷-9 (PHQ-9)。对数据进行描述性和推理性分析;在描述性分析中,给出了所调查的每个类别的绝对(FA)和相对(FR)频率;对于双变量和多变量分析,使用稳健估计的泊松回归。结果:被调查者年龄中位数为22岁,女性居多(69.7%),异性恋者居多(68.1%),主观社会地位中高(82.4%),无恋爱关系(54%)。精神药物使用率为26.1%,考虑到17.5%的人没有得到医疗专业人员的处方。使用最多的一类药物是抗抑郁药(91名参与者),其次是天然药物(38名参与者)。在与精神药物使用相关的部分中,女性个体、恋爱关系、研究生学业表现的感知以及先前的精神或情绪障碍诊断(抑郁和焦虑)。结论:研究结果强调了大学生心理健康研究的重要性,特别是精神药物的使用,必须由合格的专业人员进行监测。在大学里,这些数据除了有助于加强国家和国际伙伴关系和促进该领域的科学生产外,对于制定旨在促进健康和生活质量的政策也很重要。
{"title":"Variables Associated with the Use of Psychotropic Medications by Brazilian University Students.","authors":"Cássia Regina Primila Cardoso Berti, Alice Milani Nespollo, Moises Kogien, Evelyn Kelly Das Neves Abreu, Samira Reschetti Marcon, Tatiane Lebre Dias","doi":"10.62641/aep.v52i6.1753","DOIUrl":"10.62641/aep.v52i6.1753","url":null,"abstract":"<p><strong>Background: </strong>University life is a phase of developing personal and professional skills, but it brings challenges such as distancing from family and supporting networks, difficulties with academic tasks, loneliness, new relationships, competitiveness, and social, socioeconomic, and psychological vulnerability, among others. These conditions can lead to the development of illnesses such as anxiety, depression, sleeping disorders, suicide, self-harming, and excessive drug use, including psychotropic medications. Therefore, this study aimed to evaluate the use of psychotropic medications and its association with sociodemographic, academic, behavioral, and health variables in Brazilian university students.</p><p><strong>Methods: </strong>A cross-sectional, quantitative research, with a sampling of 524 students from a Brazilian public Higher Education Institution (Federal University of Mato Grosso - UFMT). The collection took place from October 10th to December 30th, 2022. An online questionnaire was applied with sociodemographic and clinical questions-the General Anxiety Disorder Questionnaire-7 (GAD-7) and the Patient Health Questionnaire-9 (PHQ-9). The data were descriptively and inferentially analyzed; in the descriptive analysis, the absolute (FA) and relative (FR) frequencies of each category investigated were presented; and for bi- and multivariate analyses, Poisson regression with robust estimation was used.</p><p><strong>Results: </strong>The participants were at the median age of 22 years old, the majority were female (69.7%), heterosexual (68.1%), with medium/high subjective social status (82.4%) and without being involved in a romantic relationship (54%). The prevalence of psychotropic medication use was 26.1%, considering that 17.5% was not prescribed by a medical professional. The most used class of medications was antidepressants (91 participants), followed by natural medicines (38 participants). Among the segments associated with the use of psychotropic drugs were female individuals, romantic relationships, perception of academic performance by postgraduate students, and previous diagnoses of mental or mood disorders (depression and anxiety).</p><p><strong>Conclusions: </strong>The results obtained highlight the importance of research on mental health among university students, especially regarding the use of psychotropic drugs, which must be monitored by a qualified professional. At the university, these data can be important for the development of policies aimed at health and life quality, in addition to contributing to the strengthening of national and international partnerships, and promoting the scientific production in the area.</p>","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"52 6","pages":"810-821"},"PeriodicalIF":1.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11636540/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142811865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Six-Gene Signature Related to Liquid-Liquid Phase Separation for Diagnosis of Alzheimer's Disease. 一种与液-液相分离诊断阿尔茨海默病相关的六基因标记。
IF 1 4区 医学 Q4 NEUROSCIENCES Pub Date : 2024-12-01 DOI: 10.62641/aep.v52i6.1762
Chao Qiu, Hui Xu

Background: Liquid-liquid phase separation (LLPS) has been increasingly recognized as a crucial mechanism in the pathogenesis of various neurodegenerative disorders, including Alzheimer's disease (AD). There remains a paucity of effective diagnostic biomarkers for this condition. This study aims to develop and validate a novel LLPS-related molecular signature to enhance the diagnostic accuracy and early detection of AD.

Methods: LLPS-related genes were identified from online databases and subjected to bioinformatic analyses, including protein-protein interaction (PPI) network analysis and least absolute shrinkage and selection operator (LASSO) regression. Based on the optimal LLPS-related genes, a diagnosis risk model was constructed, and the diagnostic ability was evaluated using a receiver operator characteristic (ROC) curve. To elucidate the biological functions of the identified LLPS-related genes, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were conducted.

Results: A total of 149 LLPS-related genes were screened, which were found to be involved in functions related to oxidative stress, apoptosis, and cancer progression. The 149 genes were refined to six optimal candidates through PPI network analysis and LASSO regression: Activator of HSP90 ATPase Activity 1 (AHSA1), Eukaryotic Translation Initiation Factor 2 Alpha Kinase 2 (EIF2AK2), Heat Shock Protein Family A (Hsp70) Member 4 (HSPA4), Notch Receptor 1 (NOTCH1), Superoxide Dismutase 1 (SOD1), and Thioredoxin (TXN). Based on the six optimal genes, a diagnostic risk model was constructed, and the diagnostic ability was verified to be promising in AD both in training, internal validation, and two external validation datasets, with area under ROC curve (AUC) above 0.8. Furthermore, significant correlations were observed between the expression of these genes and tumor immune cell infiltration.

Conclusions: A six-gene diagnosis model was constructed and verified to exhibit robust diagnostic ability in AD.

背景:液-液相分离(LLPS)在包括阿尔茨海默病(AD)在内的多种神经退行性疾病的发病机制中已被越来越多地认识到。对于这种情况,仍然缺乏有效的诊断性生物标志物。本研究旨在开发和验证一种新的llps相关分子特征,以提高AD的诊断准确性和早期发现。方法:从在线数据库中鉴定llps相关基因,并进行生物信息学分析,包括蛋白质-蛋白质相互作用(PPI)网络分析和最小绝对收缩和选择算子(LASSO)回归。基于优选的llps相关基因,构建诊断风险模型,采用受试者操作特征(receiver operator characteristic, ROC)曲线评估诊断能力。为了阐明鉴定的llps相关基因的生物学功能,进行了基因本体(GO)和京都基因与基因组百科全书(KEGG)分析。结果:共筛选到149个llps相关基因,发现这些基因参与氧化应激、细胞凋亡和癌症进展等相关功能。通过PPI网络分析和LASSO回归,从149个基因中筛选出6个最佳候选基因:HSP90 atp酶活性激活因子1 (AHSA1)、真核翻译起始因子2 α激酶2 (EIF2AK2)、热休克蛋白家族A (Hsp70)成员4 (HSPA4)、Notch受体1 (NOTCH1)、超氧化物歧化酶1 (SOD1)和硫氧还蛋白(TXN)。基于6个最优基因构建了诊断风险模型,在训练、内部验证和两个外部验证数据集上验证了该基因对AD的诊断能力,ROC曲线下面积(AUC)均在0.8以上。此外,这些基因的表达与肿瘤免疫细胞浸润之间存在显著相关性。结论:构建了一个六基因诊断模型,并验证了该模型对AD具有较强的诊断能力。
{"title":"A Six-Gene Signature Related to Liquid-Liquid Phase Separation for Diagnosis of Alzheimer's Disease.","authors":"Chao Qiu, Hui Xu","doi":"10.62641/aep.v52i6.1762","DOIUrl":"10.62641/aep.v52i6.1762","url":null,"abstract":"<p><strong>Background: </strong>Liquid-liquid phase separation (LLPS) has been increasingly recognized as a crucial mechanism in the pathogenesis of various neurodegenerative disorders, including Alzheimer's disease (AD). There remains a paucity of effective diagnostic biomarkers for this condition. This study aims to develop and validate a novel LLPS-related molecular signature to enhance the diagnostic accuracy and early detection of AD.</p><p><strong>Methods: </strong>LLPS-related genes were identified from online databases and subjected to bioinformatic analyses, including protein-protein interaction (PPI) network analysis and least absolute shrinkage and selection operator (LASSO) regression. Based on the optimal LLPS-related genes, a diagnosis risk model was constructed, and the diagnostic ability was evaluated using a receiver operator characteristic (ROC) curve. To elucidate the biological functions of the identified LLPS-related genes, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were conducted.</p><p><strong>Results: </strong>A total of 149 LLPS-related genes were screened, which were found to be involved in functions related to oxidative stress, apoptosis, and cancer progression. The 149 genes were refined to six optimal candidates through PPI network analysis and LASSO regression: Activator of HSP90 ATPase Activity 1 (AHSA1), Eukaryotic Translation Initiation Factor 2 Alpha Kinase 2 (EIF2AK2), Heat Shock Protein Family A (Hsp70) Member 4 (HSPA4), Notch Receptor 1 (NOTCH1), Superoxide Dismutase 1 (SOD1), and Thioredoxin (TXN). Based on the six optimal genes, a diagnostic risk model was constructed, and the diagnostic ability was verified to be promising in AD both in training, internal validation, and two external validation datasets, with area under ROC curve (AUC) above 0.8. Furthermore, significant correlations were observed between the expression of these genes and tumor immune cell infiltration.</p><p><strong>Conclusions: </strong>A six-gene diagnosis model was constructed and verified to exhibit robust diagnostic ability in AD.</p>","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"52 6","pages":"759-768"},"PeriodicalIF":1.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11636544/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142811714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Professional Responsibility of Psychologists in the Field of Mental Health in Spain. 西班牙心理健康领域心理学家的职业责任。
IF 1 4区 医学 Q4 NEUROSCIENCES Pub Date : 2024-12-01 DOI: 10.62641/aep.v52i6.1819
José Manuel Bertolín-Guillén, Andrés Porcel-Torrens, Francisca Cantero-Araque, Yolanda Morant-Luján

In Spain and many other countries, psychotherapy training is heterogeneous and not very evidence-based. This contribution addresses related ethical, normative and legal issues with the aim of clarification, as well as certain relevant aspects of psychological work in the field of mental and behavioural health in Spain. It will analyse professional responsibility and possible intrusiveness in the clinical-psychological field. The authors have scrutinised national legislation along with PubMed/Medline content, as well as a wide variety of scientific papers collected using the search engines Google Scholar and Scientific Electronic Library Online. For clinical psychologists and psychiatric doctors, when appropriate, it is their professional responsibility to choose among the various and sometimes conflicting interventions proposed as the most appropriate or priority psychotherapies. Psychotherapy, as a treatment, although not regulated, should only be undertaken by health personnel who are suitably qualified in mental health with the guarantee of the State, at least in Spain. This would probably help to mitigate the perennial crisis of replication in psychology, particularly as applied to mental health. Likewise, it is a relevant and popular issue, antagonistic to intrusiveness, that any common intervention of interpersonal psychic help should be considered therapeutic, or preferably be undertaken by personnel with a degree in psychology. There is no mandatory psychotherapeutic standard for clinical psychologists and psychiatrists, nor is there an official common international system of accreditation in clinical psychology outside Spain. In the field of mental health, any intervening psychologist, like any medical doctor, is ethically and legally responsible for their actions, omissions and consequences.

在西班牙和其他许多国家,心理治疗培训是多种多样的,而且缺乏充分的证据。这份文件涉及相关的伦理、规范和法律问题,目的是澄清问题,以及西班牙心理和行为健康领域心理工作的某些相关方面。它将分析临床心理学领域的专业责任和可能的侵入性。这组作者仔细审查了国家立法和PubMed/Medline内容,以及使用b谷歌Scholar和科学电子图书馆在线搜索引擎收集的各种科学论文。对于临床心理学家和精神科医生来说,在适当的时候,从各种各样的、有时相互冲突的干预措施中选择最合适或最优先的心理治疗是他们的职业责任。心理治疗作为一种治疗方法,虽然不受管制,但至少在西班牙,只有在国家的保障下,在心理健康方面具有适当资格的保健人员才能进行。这可能有助于缓解心理学中长期存在的复制危机,尤其是在心理健康领域。同样,这是一个相关的和流行的问题,反对侵入性,任何常见的人际心理帮助干预都应该被认为是治疗性的,或者最好是由具有心理学学位的人员进行。临床心理学家和精神科医生没有强制性的心理治疗标准,西班牙以外的临床心理学也没有官方的共同国际认证体系。在心理健康领域,任何介入的心理学家,就像任何医生一样,对他们的行为、疏忽和后果负有道德和法律责任。
{"title":"Professional Responsibility of Psychologists in the Field of Mental Health in Spain.","authors":"José Manuel Bertolín-Guillén, Andrés Porcel-Torrens, Francisca Cantero-Araque, Yolanda Morant-Luján","doi":"10.62641/aep.v52i6.1819","DOIUrl":"10.62641/aep.v52i6.1819","url":null,"abstract":"<p><p>In Spain and many other countries, psychotherapy training is heterogeneous and not very evidence-based. This contribution addresses related ethical, normative and legal issues with the aim of clarification, as well as certain relevant aspects of psychological work in the field of mental and behavioural health in Spain. It will analyse professional responsibility and possible intrusiveness in the clinical-psychological field. The authors have scrutinised national legislation along with PubMed/Medline content, as well as a wide variety of scientific papers collected using the search engines Google Scholar and Scientific Electronic Library Online. For clinical psychologists and psychiatric doctors, when appropriate, it is their professional responsibility to choose among the various and sometimes conflicting interventions proposed as the most appropriate or priority psychotherapies. Psychotherapy, as a treatment, although not regulated, should only be undertaken by health personnel who are suitably qualified in mental health with the guarantee of the State, at least in Spain. This would probably help to mitigate the perennial crisis of replication in psychology, particularly as applied to mental health. Likewise, it is a relevant and popular issue, antagonistic to intrusiveness, that any common intervention of interpersonal psychic help should be considered therapeutic, or preferably be undertaken by personnel with a degree in psychology. There is no mandatory psychotherapeutic standard for clinical psychologists and psychiatrists, nor is there an official common international system of accreditation in clinical psychology outside Spain. In the field of mental health, any intervening psychologist, like any medical doctor, is ethically and legally responsible for their actions, omissions and consequences.</p>","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"52 6","pages":"843-853"},"PeriodicalIF":1.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11636546/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142811758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Adverse Effects of Anxiety and Depression on Pregnant Women with Hypothyroidism in Late Pregnancy. 焦虑和抑郁对妊娠晚期甲状腺功能减退症孕妇的不良影响。
IF 1 4区 医学 Q4 NEUROSCIENCES Pub Date : 2024-10-01 DOI: 10.62641/aep.v52i5.1644
Jun Ma, Wenjing He, Chengfang Fan, Jianying Duan, Jiaming Wu, Cuijing Zhang, Yi Peng

Background: Maternal depression and anxiety during pregnancy are significant public health concerns commonly reported worldwide among pregnant women. This study aimed to investigate the impact of anxiety and depression on thyroid function, pregnancy outcomes, and sleep quality among pregnant women with hypothyroidism in the later stages of pregnancy.

Methods: Eighty cases of pregnant women with hypothyroidism in late pregnancy who were treated at Zhangjiakou First Hospital from January 2021 to October 2023 were selected for this retrospective study. The pregnant women in late pregnancy were divided into four groups according to the scores on the Hospital Anxiety and Depression Scale (HADS): control group with 20 cases, anxiety group with 18 cases, depression group with 22 cases, and anxiety-depression group with 20 cases. A comparison was made among the four groups regarding general information of pregnant women in late pregnancy, HADS scale scores, levels of free thyroxine (FT4, FT3), thyroid-stimulating hormone (TSH), occurrence of adverse pregnancy outcomes, and sleep quality at different time periods.

Results: There was no statistically significant difference in comparing general information among the four groups of pregnant women in late pregnancy (p > 0.05). There were statistically significant differences in HADS depression and HADS anxiety scores (p < 0.05), levels of FT4, FT3, TSH in pregnant women in late pregnancy postpartum (p < 0.05), occurrence of adverse pregnancy outcomes (p < 0.05), and comparison of sleep quality of pregnant women in late pregnancy at 1, 3, and 5 months of follow-up among the groups (F = 5.735, 23.930, 11.573, p < 0.05).

Conclusion: Anxiety and depression significantly impact thyroid function, pregnancy outcomes, and sleep quality in pregnant women with hypothyroidism in late pregnancy, which is detrimental to the health of pregnant women in late pregnancy. Therefore, necessary interventions are needed.

背景:妊娠期母亲抑郁和焦虑是全球孕妇普遍关注的重大公共卫生问题。本研究旨在探讨焦虑和抑郁对妊娠晚期甲减孕妇甲状腺功能、妊娠结局和睡眠质量的影响:本次回顾性研究选取了2021年1月至2023年10月在张家口市第一医院接受治疗的80例妊娠晚期甲减孕妇。根据医院焦虑抑郁量表(HADS)的评分,将孕晚期甲减孕妇分为四组:对照组20例,焦虑组18例,抑郁组22例,焦虑抑郁组20例。比较了四组孕妇在孕晚期的一般信息、HADS量表评分、游离甲状腺素(FT4、FT3)和促甲状腺激素(TSH)水平、不良妊娠结局的发生率以及不同时期的睡眠质量:四组孕晚期孕妇的一般信息比较差异无统计学意义(P > 0.05)。HADS抑郁和HADS焦虑评分(P<0.05)、孕晚期孕妇产后FT4、FT3、TSH水平(P<0.05)、不良妊娠结局发生率(P<0.05)以及各组孕晚期孕妇随访1、3、5个月的睡眠质量比较差异均有统计学意义(F=5.735、23.930、11.573,P<0.05):焦虑和抑郁会严重影响妊娠晚期甲减孕妇的甲状腺功能、妊娠结局和睡眠质量,不利于妊娠晚期孕妇的健康。因此,需要采取必要的干预措施。
{"title":"The Adverse Effects of Anxiety and Depression on Pregnant Women with Hypothyroidism in Late Pregnancy.","authors":"Jun Ma, Wenjing He, Chengfang Fan, Jianying Duan, Jiaming Wu, Cuijing Zhang, Yi Peng","doi":"10.62641/aep.v52i5.1644","DOIUrl":"https://doi.org/10.62641/aep.v52i5.1644","url":null,"abstract":"<p><strong>Background: </strong>Maternal depression and anxiety during pregnancy are significant public health concerns commonly reported worldwide among pregnant women. This study aimed to investigate the impact of anxiety and depression on thyroid function, pregnancy outcomes, and sleep quality among pregnant women with hypothyroidism in the later stages of pregnancy.</p><p><strong>Methods: </strong>Eighty cases of pregnant women with hypothyroidism in late pregnancy who were treated at Zhangjiakou First Hospital from January 2021 to October 2023 were selected for this retrospective study. The pregnant women in late pregnancy were divided into four groups according to the scores on the Hospital Anxiety and Depression Scale (HADS): control group with 20 cases, anxiety group with 18 cases, depression group with 22 cases, and anxiety-depression group with 20 cases. A comparison was made among the four groups regarding general information of pregnant women in late pregnancy, HADS scale scores, levels of free thyroxine (FT4, FT3), thyroid-stimulating hormone (TSH), occurrence of adverse pregnancy outcomes, and sleep quality at different time periods.</p><p><strong>Results: </strong>There was no statistically significant difference in comparing general information among the four groups of pregnant women in late pregnancy (p > 0.05). There were statistically significant differences in HADS depression and HADS anxiety scores (p < 0.05), levels of FT4, FT3, TSH in pregnant women in late pregnancy postpartum (p < 0.05), occurrence of adverse pregnancy outcomes (p < 0.05), and comparison of sleep quality of pregnant women in late pregnancy at 1, 3, and 5 months of follow-up among the groups (F = 5.735, 23.930, 11.573, p < 0.05).</p><p><strong>Conclusion: </strong>Anxiety and depression significantly impact thyroid function, pregnancy outcomes, and sleep quality in pregnant women with hypothyroidism in late pregnancy, which is detrimental to the health of pregnant women in late pregnancy. Therefore, necessary interventions are needed.</p>","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"52 5","pages":"625-631"},"PeriodicalIF":1.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11475053/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142455648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Associated Factors of Depressive Symptoms among Older Adults in the Philippines. 菲律宾老年人抑郁症状的患病率和相关因素。
IF 1 4区 医学 Q4 NEUROSCIENCES Pub Date : 2024-10-01 DOI: 10.62641/aep.v52i5.1686
Supa Pengpid, Karl Peltzer

Background: Depressive symptoms may increase with age, potentially influenced by sociodemographic characteristics, stressors and support, health status, and health behaviour. It is unclear if this is the case among older adults in the Philippines. Therefore, the aim of this study is to estimate the prevalence and associated factors of depressive symptoms among older adults in the Philippines.

Methods: In all, 5209 items of cross-sectional nationally representative data from older adults (≥60 years) participating in the 2018 Longitudinal Study on Ageing and Health in the Philippines (LSAHP) were analysed. Depressive symptoms were assessed using the 11-item 3-response category Center for Epidemiological Studies Depression (CES-D) Scale.

Results: The overall prevalence of depressive symptoms was 32.1%, with 25.6% among older men and 36.5% among older women. In the final adjusted models, overall, widowed (Adjusted Odds Ratio (AOR): 1.52, 95% Confidence Interval (CI): 1.00 to 2.30), hunger (AOR: 2.22, 95% CI: 1.40 to 3.51), living alone (AOR: 1.61, 95% CI: 1.00 to 2.59), not satisfied with present life (AOR: 2.04, 95% CI: 1.09 to 3.81), body pain (AOR: 2.39, 95% CI: 1.73 to 3.31), and insomnia (AOR: 1.69, 95% CI: 1.24 to 2.31) were positively associated, while working (AOR: 0.55, 95% CI: 0.37 to 0.80) was negatively associated with depressive symptoms. In addition, among men, older age (80 years and above) (AOR: 1.95, 95% CI: 1.06 to 3.58), unmet healthcare needs (AOR: 2.19, 95% CI: 1.07 to 4.47), and hearing difficulty (AOR: 2.41, 95% CI: 1.06 to 5.52) were positively associated poor childhood health (AOR: 0.12, 95% CI: 0.04 to 0.36), while social network (AOR: 0.94, 95% CI: 0.90 to 0.99) was negatively associated. Among women, loss of bladder control (AOR: 1.69, 95% CI: 1.03 to 2.77) was positively associated with depressive symptoms.

Conclusion: One in three older adults participating in this study exhibited depressive symptoms. Sociodemographic factors, stressors, and health status factors were positively associated, and support factors were negatively associated with depressive symptoms.

背景:抑郁症状可能会随着年龄的增长而增加,这可能会受到社会人口特征、压力和支持、健康状况和健康行为的影响。菲律宾老年人的情况是否如此尚不清楚。因此,本研究旨在估算菲律宾老年人抑郁症状的患病率和相关因素:分析了参加 2018 年菲律宾老龄化与健康纵向研究(LSAHP)的老年人(≥60 岁)的 5209 项具有全国代表性的横断面数据。抑郁症状采用流行病学研究中心抑郁(CES-D)量表的11个项目3个反应类别进行评估:抑郁症状的总体流行率为 32.1%,其中老年男性为 25.6%,老年女性为 36.5%。在最终调整模型中,总体而言,丧偶(调整比值比(AOR):1.52,95% 置信区间(CI):1.00 至 2.30)、饥饿(AOR:2.22,95% CI:1.40 至 3.51)、独居(AOR:1.61,95% CI:1.00 至 2.59)、对目前生活不满意(AOR:2.04,95% CI:1.09 至 3.81)、身体疼痛(AOR:2.39,95% CI:1.73 至 3.31)和失眠(AOR:1.69,95% CI:1.24 至 2.31)呈正相关,而工作(AOR:0.55,95% CI:0.37 至 0.80)与抑郁症状呈负相关。此外,在男性中,年龄较大(80 岁及以上)(AOR:1.95,95% CI:1.06 至 3.58)、未满足的医疗保健需求(AOR:2.19,95% CI:1.07 至 4.47)和听力困难(AOR:2.41,95% CI:1.06 至 5.52)正相关,而社会网络(AOR:0.94,95% CI:0.90 至 0.99)负相关。在女性中,膀胱失控(AOR:1.69,95% CI:1.03 至 2.77)与抑郁症状呈正相关:结论:参与本研究的老年人中,每三人中就有一人出现抑郁症状。社会人口因素、压力因素和健康状况因素与抑郁症状呈正相关,而支持因素与抑郁症状呈负相关。
{"title":"Prevalence and Associated Factors of Depressive Symptoms among Older Adults in the Philippines.","authors":"Supa Pengpid, Karl Peltzer","doi":"10.62641/aep.v52i5.1686","DOIUrl":"https://doi.org/10.62641/aep.v52i5.1686","url":null,"abstract":"<p><strong>Background: </strong>Depressive symptoms may increase with age, potentially influenced by sociodemographic characteristics, stressors and support, health status, and health behaviour. It is unclear if this is the case among older adults in the Philippines. Therefore, the aim of this study is to estimate the prevalence and associated factors of depressive symptoms among older adults in the Philippines.</p><p><strong>Methods: </strong>In all, 5209 items of cross-sectional nationally representative data from older adults (≥60 years) participating in the 2018 Longitudinal Study on Ageing and Health in the Philippines (LSAHP) were analysed. Depressive symptoms were assessed using the 11-item 3-response category Center for Epidemiological Studies Depression (CES-D) Scale.</p><p><strong>Results: </strong>The overall prevalence of depressive symptoms was 32.1%, with 25.6% among older men and 36.5% among older women. In the final adjusted models, overall, widowed (Adjusted Odds Ratio (AOR): 1.52, 95% Confidence Interval (CI): 1.00 to 2.30), hunger (AOR: 2.22, 95% CI: 1.40 to 3.51), living alone (AOR: 1.61, 95% CI: 1.00 to 2.59), not satisfied with present life (AOR: 2.04, 95% CI: 1.09 to 3.81), body pain (AOR: 2.39, 95% CI: 1.73 to 3.31), and insomnia (AOR: 1.69, 95% CI: 1.24 to 2.31) were positively associated, while working (AOR: 0.55, 95% CI: 0.37 to 0.80) was negatively associated with depressive symptoms. In addition, among men, older age (80 years and above) (AOR: 1.95, 95% CI: 1.06 to 3.58), unmet healthcare needs (AOR: 2.19, 95% CI: 1.07 to 4.47), and hearing difficulty (AOR: 2.41, 95% CI: 1.06 to 5.52) were positively associated poor childhood health (AOR: 0.12, 95% CI: 0.04 to 0.36), while social network (AOR: 0.94, 95% CI: 0.90 to 0.99) was negatively associated. Among women, loss of bladder control (AOR: 1.69, 95% CI: 1.03 to 2.77) was positively associated with depressive symptoms.</p><p><strong>Conclusion: </strong>One in three older adults participating in this study exhibited depressive symptoms. Sociodemographic factors, stressors, and health status factors were positively associated, and support factors were negatively associated with depressive symptoms.</p>","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"52 5","pages":"705-715"},"PeriodicalIF":1.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11474966/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142455642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Intersection between Tryptophan-Kynurenine Pathway Metabolites and Immune Inflammation, Hormones, and Gut Microbiota in Perinatal Depression. 围产期抑郁症中色氨酸-犬尿氨酸途径代谢物与免疫炎症、激素和肠道微生物群之间的交集
IF 1 4区 医学 Q4 NEUROSCIENCES Pub Date : 2024-10-01 DOI: 10.62641/aep.v52i5.1748
Huiyan Liu, Kuangyi Zhu, Cheng Yang

Perinatal depression is a prevalent mental disorder among pregnant women, characterized by sleep disturbances, appetite changes, negative emotions, cognitive impairment, and suicidal or homicidal tendencies. These symptoms severely compromise personal well-being, disrupt family life, and burden society. Early detection and intervention are thus crucial. The tryptophan-kynurenine (TRP-KYN) pathway is central to the inflammatory hypothesis of depression and has gained significant attention in perinatal depression research. This pathway encompasses numerous metabolic enzymes and neuroactive metabolites that interact with other physiological systems, influencing neurotransmitter synthesis and neuronal development. Through these interactions, the TRP-KYN pathway exerts psychotropic effects. This article reviews the key metabolites and enzymes of the TRP-KYN pathway and examines its intersection with immune inflammation, hormones, and gut microbiota.

围产期抑郁症是孕妇中普遍存在的一种精神障碍,主要表现为睡眠障碍、食欲改变、负面情绪、认知障碍以及自杀或杀人倾向。这些症状严重损害了个人幸福,破坏了家庭生活,并给社会造成负担。因此,早期发现和干预至关重要。色氨酸-犬尿氨酸(TRP-KYN)通路是抑郁症炎症假说的核心,在围产期抑郁症研究中备受关注。该通路包括许多代谢酶和神经活性代谢产物,它们与其他生理系统相互作用,影响神经递质的合成和神经元的发育。通过这些相互作用,TRP-KYN 途径产生了精神作用。本文回顾了 TRP-KYN 通路的关键代谢物和酶,并研究了其与免疫炎症、激素和肠道微生物群的相互关系。
{"title":"The Intersection between Tryptophan-Kynurenine Pathway Metabolites and Immune Inflammation, Hormones, and Gut Microbiota in Perinatal Depression.","authors":"Huiyan Liu, Kuangyi Zhu, Cheng Yang","doi":"10.62641/aep.v52i5.1748","DOIUrl":"https://doi.org/10.62641/aep.v52i5.1748","url":null,"abstract":"<p><p>Perinatal depression is a prevalent mental disorder among pregnant women, characterized by sleep disturbances, appetite changes, negative emotions, cognitive impairment, and suicidal or homicidal tendencies. These symptoms severely compromise personal well-being, disrupt family life, and burden society. Early detection and intervention are thus crucial. The tryptophan-kynurenine (TRP-KYN) pathway is central to the inflammatory hypothesis of depression and has gained significant attention in perinatal depression research. This pathway encompasses numerous metabolic enzymes and neuroactive metabolites that interact with other physiological systems, influencing neurotransmitter synthesis and neuronal development. Through these interactions, the TRP-KYN pathway exerts psychotropic effects. This article reviews the key metabolites and enzymes of the TRP-KYN pathway and examines its intersection with immune inflammation, hormones, and gut microbiota.</p>","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"52 5","pages":"733-740"},"PeriodicalIF":1.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11475056/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142455650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effectiveness and Safety Analysis of Duloxetine in Treating Comorbid Depression in Parkinson's Disease: A Retrospective Study. 度洛西汀治疗帕金森病合并抑郁症的有效性和安全性分析:一项回顾性研究
IF 1 4区 医学 Q4 NEUROSCIENCES Pub Date : 2024-10-01 DOI: 10.62641/aep.v52i5.1634
Zhuoqun Wang, Jing Tian, Weixin Dai, Na Zhang, Jianglin Wang, Zhanyu Li

Background: Parkinson's disease (PD) is a neurodegenerative disorder characterized by both motor and non-motor symptoms, including depression, which significantly impacts the quality of life of affected individuals. This study aims to investigate the real-world effectiveness and safety of duloxetine in treating comorbid depression in patients with Parkinson's disease and to compare its outcomes with traditional treatment approaches.

Methods: This study included adult patients diagnosed with Parkinson's disease combined with depression from December 2020 to December 2023. Based on the use of duloxetine, the cohort was divided into a traditional treatment group and a duloxetine group (traditional treatment combined with duloxetine). Patients with incomplete medical records, concurrent antidepressant therapy, or major psychiatric or neurological disorders were excluded. Retrospective data, including demographic information, treatment adherence, and various assessment scores, were collected from medical records by trained research staff.

Results: In total, 106 patients were analyzed, with 50 patients receiving traditional treatment and 56 patients receiving duloxetine. The duloxetine group exhibited significantly lower scores than the traditional treatment group in the Unified PD Rating Scale (p = 0.015), Hamilton Depression Rating Scale (p = 0.013), Beck Depression Inventory (p = 0.031), Parkinson's disease Questionnaire-39 (p = 0.006), and Clinical Global Impression-Improvement (p < 0.001) scores. In motor function assessment, the duloxetine group demonstrated improvements in kinetic tremor scores (p = 0.017), gait speed (p < 0.001), Timed Up and Go Test performance (p < 0.001), dyskinesia severity (p = 0.017), and rigidity (p = 0.019) compared to the traditional treatment group. Additionally, the duloxetine group exhibited better cognitive function across various assessments, including the Symbol Digit Modalities Test (p = 0.024), Stroop Color-Word Test (p = 0.048), and Montreal Cognitive Assessment (p = 0.024).

Conclusion: Duloxetine is associated with superior efficacy in improving motor and non-motor symptoms, overall clinical status, and cognitive function. These findings support the potential utility of duloxetine as a comprehensive treatment option for comorbid depression in Parkinson's disease.

背景:帕金森病(PD)是一种神经退行性疾病,以运动症状和非运动症状(包括抑郁)为特征,严重影响患者的生活质量。本研究旨在探讨度洛西汀治疗帕金森病患者合并抑郁症的实际有效性和安全性,并将其结果与传统治疗方法进行比较:本研究纳入了 2020 年 12 月至 2023 年 12 月期间确诊为帕金森病合并抑郁症的成年患者。根据度洛西汀的使用情况,队列被分为传统治疗组和度洛西汀组(传统治疗联合度洛西汀)。病历不完整、同时接受抗抑郁治疗或患有严重精神或神经疾病的患者被排除在外。经过培训的研究人员从病历中收集了回顾性数据,包括人口统计学信息、治疗依从性和各种评估评分:共对106名患者进行了分析,其中50名患者接受了传统治疗,56名患者接受了度洛西汀治疗。度洛西汀组的统一帕金森病评分量表(p = 0.015)、汉密尔顿抑郁评分量表(p = 0.013)、贝克抑郁量表(p = 0.031)、帕金森病问卷-39(p = 0.006)和临床总体印象-改善(p < 0.001)得分均显著低于传统治疗组。在运动功能评估中,与传统治疗组相比,度洛西汀组在运动性震颤评分(p = 0.017)、步态速度(p < 0.001)、定时上下楼测试成绩(p < 0.001)、运动障碍严重程度(p = 0.017)和僵直(p = 0.019)方面均有改善。此外,度洛西汀组在各种评估中表现出更好的认知功能,包括符号数字模型测试(p = 0.024)、Stroop颜色词测试(p = 0.048)和蒙特利尔认知评估(p = 0.024):结论:度洛西汀在改善运动和非运动症状、整体临床状态和认知功能方面具有卓越疗效。这些研究结果支持度洛西汀作为帕金森病合并抑郁症综合治疗方案的潜在作用。
{"title":"The Effectiveness and Safety Analysis of Duloxetine in Treating Comorbid Depression in Parkinson's Disease: A Retrospective Study.","authors":"Zhuoqun Wang, Jing Tian, Weixin Dai, Na Zhang, Jianglin Wang, Zhanyu Li","doi":"10.62641/aep.v52i5.1634","DOIUrl":"https://doi.org/10.62641/aep.v52i5.1634","url":null,"abstract":"<p><strong>Background: </strong>Parkinson's disease (PD) is a neurodegenerative disorder characterized by both motor and non-motor symptoms, including depression, which significantly impacts the quality of life of affected individuals. This study aims to investigate the real-world effectiveness and safety of duloxetine in treating comorbid depression in patients with Parkinson's disease and to compare its outcomes with traditional treatment approaches.</p><p><strong>Methods: </strong>This study included adult patients diagnosed with Parkinson's disease combined with depression from December 2020 to December 2023. Based on the use of duloxetine, the cohort was divided into a traditional treatment group and a duloxetine group (traditional treatment combined with duloxetine). Patients with incomplete medical records, concurrent antidepressant therapy, or major psychiatric or neurological disorders were excluded. Retrospective data, including demographic information, treatment adherence, and various assessment scores, were collected from medical records by trained research staff.</p><p><strong>Results: </strong>In total, 106 patients were analyzed, with 50 patients receiving traditional treatment and 56 patients receiving duloxetine. The duloxetine group exhibited significantly lower scores than the traditional treatment group in the Unified PD Rating Scale (p = 0.015), Hamilton Depression Rating Scale (p = 0.013), Beck Depression Inventory (p = 0.031), Parkinson's disease Questionnaire-39 (p = 0.006), and Clinical Global Impression-Improvement (p < 0.001) scores. In motor function assessment, the duloxetine group demonstrated improvements in kinetic tremor scores (p = 0.017), gait speed (p < 0.001), Timed Up and Go Test performance (p < 0.001), dyskinesia severity (p = 0.017), and rigidity (p = 0.019) compared to the traditional treatment group. Additionally, the duloxetine group exhibited better cognitive function across various assessments, including the Symbol Digit Modalities Test (p = 0.024), Stroop Color-Word Test (p = 0.048), and Montreal Cognitive Assessment (p = 0.024).</p><p><strong>Conclusion: </strong>Duloxetine is associated with superior efficacy in improving motor and non-motor symptoms, overall clinical status, and cognitive function. These findings support the potential utility of duloxetine as a comprehensive treatment option for comorbid depression in Parkinson's disease.</p>","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"52 5","pages":"607-615"},"PeriodicalIF":1.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11475055/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142455649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insights and Reflections on Cognitive Behavioural and Dialectical Behavioural Therapies for Adolescent Self-Harm and Suicidal Behavior. 对认知行为疗法和辩证行为疗法治疗青少年自残和自杀行为的见解和思考。
IF 1 4区 医学 Q4 NEUROSCIENCES Pub Date : 2024-10-01 DOI: 10.62641/aep.v52i5.1815
Guilherme Nobre Nogueira

No abstract present.

无摘要。
{"title":"Insights and Reflections on Cognitive Behavioural and Dialectical Behavioural Therapies for Adolescent Self-Harm and Suicidal Behavior.","authors":"Guilherme Nobre Nogueira","doi":"10.62641/aep.v52i5.1815","DOIUrl":"10.62641/aep.v52i5.1815","url":null,"abstract":"<p><p>No abstract present.</p>","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"52 5","pages":"748-749"},"PeriodicalIF":1.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11475050/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142455638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Calycosin-7-O-β-D-Glucoside Ameliorates Palmitate-Induced Lipid Accumulation in HT22 Cells. 萼萼苷-7-O-β-D-葡萄糖苷可改善棕榈酸酯诱导的 HT22 细胞脂质积累。
IF 1 4区 医学 Q4 NEUROSCIENCES Pub Date : 2024-10-01 DOI: 10.62641/aep.v52i5.1723
Yanming Xu, Dalong Li, Ao Xue, Jiaming Gu, Yifan Ren, Siyu Zhu, Xia Lei, Jianxin Liu, Jihui Zhao, Fang Geng, Ning Zhang

Background: The pathogenesis of Alzheimer's disease (AD) is complex. Recent research suggests that AD patients have early disorders in brain cholesterol metabolism. Cholesterol and its derivatives accumulate in neurons, leading to p-Tau overproduction and synaptic dysfunction, initiating AD progression. Calycosin-7-O-β-D-glucoside (CG), a distinctive constituent of Astragali Radix, holds a representative position. Many clinical trials have demonstrated that CG can attenuate cerebral ischemia/reperfusion injury and preserve the structural integrity of the blood-brain barrier. However, whether CG alleviates tau-mediated neurodegeneration by increasing cholesterol efflux after lipid accumulation remains unexplored.

Methods: Ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS/MS) and multivariate data analysis were employed to investigate metabolic changes in HT22 cells induced by sodium palmitate following 24 hours of CG treatment. The potential therapeutic mechanisms of CG on AD were further examined through Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis.

Results: Metabolomic analysis characterized 24 potential biomarkers, revealing that CG could ameliorate cholesterol metabolic pathways. The results of cell experiments revealed that CG can increase the expression of enzyme cholesterol 24-hydroxylase (CYP46A1) (p < 0.05) and the level of 24 hydroxycholesterol (24-OHC) (p < 0.05), reduce the expression of p-Tau (Thr231)/Tau (p < 0.01), inhibit the formation of lipid droplets.

Conclusion: CG may inhibit the accumulation of cholesterol and its derivatives in neurons by affecting the CYP46A1-CE-Tau axis, offering a potential therapeutic strategy for AD.

背景:阿尔茨海默病(AD)的发病机制十分复杂。最新研究表明,阿尔茨海默病患者早期大脑胆固醇代谢紊乱。胆固醇及其衍生物在神经元中积聚,导致 p-Tau 生成过多和突触功能障碍,从而引发阿尔茨海默病的进展。黄芪的独特成分萼萼苷-7-O-β-D-葡萄糖苷(CG)具有代表性。许多临床试验表明,萼苷-7-O-β-D-葡萄糖苷可以减轻脑缺血再灌注损伤,保护血脑屏障结构的完整性。然而,CG是否能通过增加脂质积累后的胆固醇外流来缓解tau介导的神经退行性变仍有待研究:方法:采用超高效液相色谱/四极杆飞行时间质谱法(UPLC-Q-TOF-MS/MS)和多元数据分析研究棕榈酸钠诱导的HT22细胞在CG处理24小时后的代谢变化。通过京都基因和基因组百科全书(KEGG)通路富集分析,进一步研究了CG对AD的潜在治疗机制:结果:代谢组分析鉴定了24个潜在的生物标记物,揭示了CG可以改善胆固醇代谢途径。细胞实验结果显示,CG能增加胆固醇24-羟化酶(CYP46A1)的表达(p < 0.05)和24-羟基胆固醇(24-OHC)的水平(p < 0.05),降低p-Tau(Thr231)/Tau的表达(p < 0.01),抑制脂滴的形成:结论:CG可通过影响CYP46A1-CE-Tau轴抑制胆固醇及其衍生物在神经元中的积累,为AD提供了一种潜在的治疗策略。
{"title":"Calycosin-7-O-β-D-Glucoside Ameliorates Palmitate-Induced Lipid Accumulation in HT22 Cells.","authors":"Yanming Xu, Dalong Li, Ao Xue, Jiaming Gu, Yifan Ren, Siyu Zhu, Xia Lei, Jianxin Liu, Jihui Zhao, Fang Geng, Ning Zhang","doi":"10.62641/aep.v52i5.1723","DOIUrl":"https://doi.org/10.62641/aep.v52i5.1723","url":null,"abstract":"<p><strong>Background: </strong>The pathogenesis of Alzheimer's disease (AD) is complex. Recent research suggests that AD patients have early disorders in brain cholesterol metabolism. Cholesterol and its derivatives accumulate in neurons, leading to p-Tau overproduction and synaptic dysfunction, initiating AD progression. Calycosin-7-O-β-D-glucoside (CG), a distinctive constituent of Astragali Radix, holds a representative position. Many clinical trials have demonstrated that CG can attenuate cerebral ischemia/reperfusion injury and preserve the structural integrity of the blood-brain barrier. However, whether CG alleviates tau-mediated neurodegeneration by increasing cholesterol efflux after lipid accumulation remains unexplored.</p><p><strong>Methods: </strong>Ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS/MS) and multivariate data analysis were employed to investigate metabolic changes in HT22 cells induced by sodium palmitate following 24 hours of CG treatment. The potential therapeutic mechanisms of CG on AD were further examined through Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis.</p><p><strong>Results: </strong>Metabolomic analysis characterized 24 potential biomarkers, revealing that CG could ameliorate cholesterol metabolic pathways. The results of cell experiments revealed that CG can increase the expression of enzyme cholesterol 24-hydroxylase (CYP46A1) (p < 0.05) and the level of 24 hydroxycholesterol (24-OHC) (p < 0.05), reduce the expression of p-Tau (Thr231)/Tau (p < 0.01), inhibit the formation of lipid droplets.</p><p><strong>Conclusion: </strong>CG may inhibit the accumulation of cholesterol and its derivatives in neurons by affecting the CYP46A1-CE-Tau axis, offering a potential therapeutic strategy for AD.</p>","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"52 5","pages":"641-652"},"PeriodicalIF":1.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11475025/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142455636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the Reliability, Dimensions, and Variance of Young's Internet Addiction Test by Applying it to Adolescents at the National Psychiatric Hospital in Costa Rica. 通过对哥斯达黎加国家精神病医院的青少年进行测试,评估杨氏网络成瘾测试的可靠性、维度和方差。
IF 1 4区 医学 Q4 NEUROSCIENCES Pub Date : 2024-10-01 DOI: 10.62641/aep.v52i5.1845
José A Martín Herrero, Karla Fernández Mora, Antonio Molina Fernández

Background: The Internet Addiction Test (IAT) was the first instrument created specifically to assess Internet addiction (IA). Although it was not validated during its creation, its validity has since been confirmed thanks to subsequent studies. The IAT is the first global psychometric measure tested worldwide that has been used in several studies as a research tool. Regarding the dimensions of the IAT, they were not reported by the creator of the test, during the performed factor analysis. Nonetheless, different studies have defined the test as being one-dimensional and others as having three, four, five, and six dimensions.

Methods: In the present study, seven dimensions were identified; however, there is still a lack of consensus about the number of dimensions that accurately define this test.

Results: Hence, Young's Internet Addiction Test presents a shortcoming that may be explained by the influence of several factors such as how it was applied, the place where it was applied, and the population to which it was applied. All of these are factors that could be linked to the sociocultural aspects of the adaptations that have been made to the test.

Conclusions: Moreover, the first dimension of the IAT found, the loss of self-control, is extremely important because it explains 34% of the variance of the data. However, 74% of the variance is explained by applying the 7 dimensions identified in this research. Also, the reliability analysis showed that the IAT is 89% reliable, which indicates that the elements comprising the test used in this research are suitable for measuring the construct of Internet addiction.

背景:网络成瘾测试(IAT)是第一个专门用于评估网络成瘾(IA)的工具。虽然在设计之初没有经过验证,但后来的研究证实了它的有效性。IAT 是第一个在全球范围内进行测试的全球性心理测量工具,已被多项研究用作研究工具。关于 IAT 的维度,在进行因子分析时,测试的创建者并没有报告。不过,不同的研究将该测验定义为一维测验,也有研究将其定义为三维、四维、五维和六维测验:方法:本研究确定了七个维度;然而,关于准确定义该测试的维度数量仍缺乏共识:因此,杨氏网瘾测试的不足之处可能是受多种因素的影响,如应用方式、应用地点和应用人群等。所有这些因素都可能与该测试的社会文化适应性有关:此外,所发现的 IAT 的第一个维度--自制力丧失--极为重要,因为它解释了 34% 的数据方差。然而,通过应用本研究确定的 7 个维度,可以解释 74% 的方差。此外,信度分析表明,IAT 的信度为 89%,这表明本研究中使用的测试元素适合测量网络成瘾的结构。
{"title":"Assessing the Reliability, Dimensions, and Variance of Young's Internet Addiction Test by Applying it to Adolescents at the National Psychiatric Hospital in Costa Rica.","authors":"José A Martín Herrero, Karla Fernández Mora, Antonio Molina Fernández","doi":"10.62641/aep.v52i5.1845","DOIUrl":"https://doi.org/10.62641/aep.v52i5.1845","url":null,"abstract":"<p><strong>Background: </strong>The Internet Addiction Test (IAT) was the first instrument created specifically to assess Internet addiction (IA). Although it was not validated during its creation, its validity has since been confirmed thanks to subsequent studies. The IAT is the first global psychometric measure tested worldwide that has been used in several studies as a research tool. Regarding the dimensions of the IAT, they were not reported by the creator of the test, during the performed factor analysis. Nonetheless, different studies have defined the test as being one-dimensional and others as having three, four, five, and six dimensions.</p><p><strong>Methods: </strong>In the present study, seven dimensions were identified; however, there is still a lack of consensus about the number of dimensions that accurately define this test.</p><p><strong>Results: </strong>Hence, Young's Internet Addiction Test presents a shortcoming that may be explained by the influence of several factors such as how it was applied, the place where it was applied, and the population to which it was applied. All of these are factors that could be linked to the sociocultural aspects of the adaptations that have been made to the test.</p><p><strong>Conclusions: </strong>Moreover, the first dimension of the IAT found, the loss of self-control, is extremely important because it explains 34% of the variance of the data. However, 74% of the variance is explained by applying the 7 dimensions identified in this research. Also, the reliability analysis showed that the IAT is 89% reliable, which indicates that the elements comprising the test used in this research are suitable for measuring the construct of Internet addiction.</p>","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"52 5","pages":"598-606"},"PeriodicalIF":1.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11474969/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142455635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Actas espanolas de psiquiatria
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1